Terms: = Ovarian cancer AND EBF1, COE1, 1879, ENSG00000164330, Q9UH73, OLF1, O/E-1, EBF
30 results:
1. Association of long-term particulate matter exposure with all-cause mortality among patients with ovarian cancer: A prospective cohort.
Li YZ; Huang SH; Shi S; Chen WX; Wei YF; Zou BJ; Yao W; Zhou L; Liu FH; Gao S; Yan S; Qin X; Zhao YH; Chen RJ; Gong TT; Wu QJ
Sci Total Environ; 2023 Aug; 884():163748. PubMed ID: 37120017
[TBL] [Abstract] [Full Text] [Related]
2. Purine Intake and All-Cause Mortality in ovarian cancer: Results from a Prospective Cohort Study.
Du Z; Gong T; Wei Y; Zheng G; Zhao J; Zou B; Qin X; Yan S; Liu F; Xiao Q; Wu Q; Gao S; Zhao Y
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839289
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian study.
Abdel-Razeq H; Al-Azzam K; Elemian S; Abu-Fares H; Abu Sheikha A; Bani Hani H; Bater R; Sharaf B; Heald B; Esplin ED; Nielsen SM; Alkyam M; Abujamous L; Al-Attary A
Mol Genet Genomic Med; 2023 Apr; 11(4):e2125. PubMed ID: 36537080
[TBL] [Abstract] [Full Text] [Related]
4. Pre-diagnosis fiber : carbohydrate intake ratio and mortality of ovarian cancer: results from a prospective cohort study.
Liu FH; Du ZD; Li XY; Wei YF; Wen ZY; Yan S; Sun ML; Qin X; Gao S; Gong TT; Wu QJ
Food Funct; 2022 Oct; 13(19):10046-10054. PubMed ID: 36093635
[No Abstract] [Full Text] [Related]
5. Association between pre-diagnostic dietary pattern and survival of ovarian cancer: Evidence from a prospective cohort study.
Wen ZY; Liu C; Liu FH; Wei YF; Xu HL; Wang R; Li XY; Li YZ; Yan S; Qin X; Gao S; Li XQ; Zhao YH; Gong TT; Wu QJ
Clin Nutr; 2022 Feb; 41(2):452-459. PubMed ID: 35007814
[TBL] [Abstract] [Full Text] [Related]
6. Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up.
Casper AC; Parsons MW; Chipman J; Burt LM; Suneja G; Maurer KA; Gaffney DK
Gynecol Oncol; 2021 Aug; 162(2):454-460. PubMed ID: 34092413
[TBL] [Abstract] [Full Text] [Related]
7. Racial-Ethnic Comparison of Guideline-Adherent Gynecologic cancer Care in an Equal-Access System.
Eaglehouse YL; Darcy KM; Tian C; Casablanca Y; Shriver CD; Zhu K
Obstet Gynecol; 2021 Apr; 137(4):629-640. PubMed ID: 33706355
[TBL] [Abstract] [Full Text] [Related]
8. Long-term survival outcome of advanced epithelial ovarian cancer: A single institutional study.
Viral P; Rajanbabu A; Pavithran K; Chithrathara K; Nair IR; Bhaskaran R; Gangadharan P; Vijaykumar DK
Indian J Cancer; 2021; 58(3):342-348. PubMed ID: 33402564
[TBL] [Abstract] [Full Text] [Related]
9. Population frequencies of pathogenic alleles of BRCA1 and BRCA2: analysis of 173 Danish breast cancer pedigrees using the BOADICEA model.
Terkelsen T; Christensen LL; Fenton DC; Jensen UB; Sunde L; Thomassen M; Skytte AB
Fam Cancer; 2019 Oct; 18(4):381-388. PubMed ID: 31435815
[TBL] [Abstract] [Full Text] [Related]
10. ovarian primary primitive neuroectodermal tumor: a review of cases at PUMCH and in the published literature.
Chao X; Bi Y; Li L
Orphanet J Rare Dis; 2019 Jun; 14(1):147. PubMed ID: 31217017
[TBL] [Abstract] [Full Text] [Related]
11. Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials.
George A; Kristeleit R; Rafii S; Michie CO; Bowen R; Michalarea V; van Hagen T; Wong M; Rallis G; Molife LR; Lopez J; Banerji U; Banerjee SN; Gore ME; de Bono JS; Kaye SB; Yap TA
Eur J Cancer; 2017 May; 76():52-59. PubMed ID: 28273485
[TBL] [Abstract] [Full Text] [Related]
12. Young premenopausal women with breast cancer, especially estrogen receptor negative, are at significantly increased risk for subsequent ovarian cancer.
Lehrer S; Rheinstein PH; Green S; Rosenzweig KE
Discov Med; 2016 Oct; 22(121):209-213. PubMed ID: 27875672
[TBL] [Abstract] [Full Text] [Related]
13. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.
Galvan-Turner VB; Chang J; Ziogas A; Bristow RE
Gynecol Oncol; 2015 Dec; 139(3):495-9. PubMed ID: 26387962
[TBL] [Abstract] [Full Text] [Related]
14. Glycemic index, glycemic load and endometrial cancer risk: results from the Australian National Endometrial cancer study and an updated systematic review and meta-analysis.
Nagle CM; Olsen CM; Ibiebele TI; Spurdle AB; Webb PM; ;
Eur J Nutr; 2013 Mar; 52(2):705-15. PubMed ID: 22648201
[TBL] [Abstract] [Full Text] [Related]
15. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
[TBL] [Abstract] [Full Text] [Related]
16. Dietary patterns and ovarian cancer risk.
Kolahdooz F; Ibiebele TI; van der Pols JC; Webb PM
Am J Clin Nutr; 2009 Jan; 89(1):297-304. PubMed ID: 19056595
[TBL] [Abstract] [Full Text] [Related]
17. Epithelial ovarian cancer: testing the 'androgens hypothesis'.
Olsen CM; Green AC; Nagle CM; Jordan SJ; Whiteman DC; Bain CJ; Webb PM;
Endocr Relat Cancer; 2008 Dec; 15(4):1061-8. PubMed ID: 18772244
[TBL] [Abstract] [Full Text] [Related]
18. Body size and risk of epithelial ovarian and related cancers: a population-based case-control study.
Olsen CM; Nagle CM; Whiteman DC; Purdie DM; Green AC; Webb PM
Int J Cancer; 2008 Jul; 123(2):450-456. PubMed ID: 18449887
[TBL] [Abstract] [Full Text] [Related]
19. The influence of reproductive and hormonal factors on ovarian cancer survival.
Nagle CM; Bain CJ; Green AC; Webb PM
Int J Gynecol Cancer; 2008; 18(3):407-13. PubMed ID: 17645507
[TBL] [Abstract] [Full Text] [Related]
20. Timing of pregnancy and the risk of epithelial ovarian cancer.
Whiteman DC; Siskind V; Purdie DM; Green AC
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
[TBL] [Abstract] [Full Text] [Related]
[Next]
